Alembic Pharma Gets ₹331 Million GST Demand For Excess Refund Under Budgetary Scheme

Alembic Pharmaceuticals Ltd. has received a ₹331.10 million tax demand from the CGST assistant commissioner in Sikkim. This includes ₹228.31 million in tax and ₹103.75 million in interest.

The demand pertains to alleged excess refunds under the GST Budgetary Support Scheme for 2017-18 to 2024-25, across units including those in Sikkim. Alembic said it will challenge the order before the appellate authority.